Abstract
The analysis of pleural fluid (PF) is the most important diagnostic element in identifying the cause of pleural effusions. The measurement of proteins and lactate dehydrogenase in PF and blood establishes the transudative or exudative nature of effusions. Elevated concentrations of natriuretic peptide NT-proBNP (>1500 pg/mL) are virtually pathognomonic of heart failure. In exudates with predominantly polymorphonuclear leukocytes (>50%), a bacterial infection of the pleural space should be considered, particularly if pleural fluid C-reactive protein levels are high. A pleural pH <7.20 in a parapneumonic effusion is an indication for the need of a drainage tube. When lymphocytes predominate in an exudate, cancer and tuberculosis are the two main diagnoses to consider; an adenosine deaminase activity >35 U/L strongly supports the diagnosis of tuberculosis. The cytological study of PF is negative in 40% of malignant effusions. Performing immunocytochemistry on the cell block and measuring tumor markers, such as mesothelin, can increase the diagnostic yield for malignancy.
Keywords: Empyema, malignant pleural effusion, pleural effusion, tuberculous pleuritis, tumor markers.
Current Respiratory Medicine Reviews
Title:The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice
Volume: 8 Issue: 5
Author(s): Jose M. Porcel
Affiliation:
Keywords: Empyema, malignant pleural effusion, pleural effusion, tuberculous pleuritis, tumor markers.
Abstract: The analysis of pleural fluid (PF) is the most important diagnostic element in identifying the cause of pleural effusions. The measurement of proteins and lactate dehydrogenase in PF and blood establishes the transudative or exudative nature of effusions. Elevated concentrations of natriuretic peptide NT-proBNP (>1500 pg/mL) are virtually pathognomonic of heart failure. In exudates with predominantly polymorphonuclear leukocytes (>50%), a bacterial infection of the pleural space should be considered, particularly if pleural fluid C-reactive protein levels are high. A pleural pH <7.20 in a parapneumonic effusion is an indication for the need of a drainage tube. When lymphocytes predominate in an exudate, cancer and tuberculosis are the two main diagnoses to consider; an adenosine deaminase activity >35 U/L strongly supports the diagnosis of tuberculosis. The cytological study of PF is negative in 40% of malignant effusions. Performing immunocytochemistry on the cell block and measuring tumor markers, such as mesothelin, can increase the diagnostic yield for malignancy.
Export Options
About this article
Cite this article as:
Porcel M. Jose, The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice, Current Respiratory Medicine Reviews 2012; 8 (5) . https://dx.doi.org/10.2174/157339812803832485
DOI https://dx.doi.org/10.2174/157339812803832485 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Valve Endothelial Cells – Not Just Any Old Endothelial Cells
Current Vascular Pharmacology Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
Current Medicinal Chemistry Medicinal Properties of the Jamaican Pepper Plant Pimenta dioica and Allspice
Current Drug Targets Editorial [Hot Topic: New Medicinal Chemistry Approaches for the Treatment of Cardiovascular Disease (Guest Editor: Dennis Lee)]
Current Topics in Medicinal Chemistry Targeting the EGF/HER Ligand-Receptor System in Cancer
Current Pharmaceutical Design Human Cognitive and Neuro-Psychiatric Bio-Markers in the Cardiac Peri-Operative Patient
Current Molecular Medicine Comparison of Clinical Outcomes Between Genders Following Antihypertensive Therapy: A Meta-Analysis
Current Medicinal Chemistry Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets Blood Pressure and the Risk of Dementia: A Dose-Response Meta-Analysis of Prospective Studies
Current Neurovascular Research Lifestyle Modifications in the Treatment of Hypertension
Current Hypertension Reviews Some Developments Regarding Functional Food Products (Functional Foods)
Current Nutrition & Food Science Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry Effects of Glucagon-like Peptide-1 Receptor Agonists and Sodium-glucose Cotransporter 2 Inhibitors on Cardiorenal and Metabolic Outcomes in People Without Diabetes
Current Pharmaceutical Design A Systems Medicine Clinical Platform for Understanding and Managing Non- Communicable Diseases
Current Pharmaceutical Design Drug Targeting of Estrogen Receptor Signaling in the Cardiovascular System: Preclinical and Clinical Studies
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Cinnamic Acid Derivatives as Anticancer Agents-A Review
Current Medicinal Chemistry Fluoride Interactions: From Molecules to Disease
Current Signal Transduction Therapy Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)
Current Vascular Pharmacology Characteristics of Brain Tumor Stem Cells and the Rationale for Applying Tyrosine Kinase Inhibitors as Potential Targeting Agents
Recent Patents on Regenerative Medicine